BackCelularity- Warrants (16/07/2026) Overview

Celularity- Warrants (16/07/2026) Intangible Assets

Celularity- Warrants (16/07/2026)'s intangible assets is $7.8M.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$7.76M
16.13% YoYΔ $-1.49M vs prior year quarter

Peer trimmed avg / median

Loading

Celularity- Warrants (16/07/2026) Intangible Assets History

Loading

Celularity- Warrants (16/07/2026) vs. peers: Intangible Assets Comparison

Loading

Celularity- Warrants (16/07/2026) Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Celularity- Warrants (16/07/2026) (CELUW) FAQ

As of the most recent data (December 2025), CELUW shows a intangible assets of $7.8M. That compares with $9.2M in the prior-year period — down 16.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CELUW's intangible assets is now $7.8M (was $9.2M) — a 16.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Celularity- Warrants (16/07/2026) is outperforming or lagging.

Tracking CELUW's intangible assets over time shows whether Celularity- Warrants (16/07/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $7.8M That compares with $9.2M in the prior-year period — down 16.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this intangible assets page, Stockcircle has Celularity- Warrants (16/07/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $7.8M) with ownership activity and broader fundamentals.

Celularity- Warrants (16/07/2026)'s intangible assets is $7.8M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.